Prenatal DHA.

The gap this formula speaks to.

Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.

Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.

Every one of these is a fact the engine could ground.

Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.

• Studied in people20 human studies on Vitamin D3 back this formula, each one cited.
• A mechanism that is settledHow Vitamin D3 and EPA work is settled pharmacology.
• Studied together, not just separatelyEPA and DHA have been studied together, not only separately.
• Recent work on the recordThe most recent study on this record was published in 2026.
• Serving amount inside the studied rangeEach serving carries 480 mg of DHA, inside the range the published research used.
• A stated daily maintenance amountDHA is here at a daily maintenance amount, which is what a daily supplement is for.
• Why this formatIt is a softgel, so the active is already dissolved in oil and the shell keeps it away from air and light.
• The exact form, describedThe label names its forms exactly: Vitamin D3 in a carrier oil, lanolin-derived, EPA ethyl ester, EE, Algal oil, triglyceride form. The record says what each one is and what it suits.
• A declared blend totalTotal Omega-3s declares its total, 830 mg per serving, with 2 ingredients listed by weight.
• Where it comes from and how it is madeVitamin D3 is made by more than one route.
• Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
• A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.

What the trials show about timing.

Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.

• Vitamin D3about 3 months of daily useBuilds with daily use

  In the trial record, blood vitamin D rises for about 3 months of daily vitamin D3 and then holds at a plateau, near 69 nmol/L at 1,000 IU a day, from a starting level near 41 nmol/L.

  Vieth et al., 2001 (Am J Clin Nutr)PMID 11157326

  Early
• EPAabout 4 to 8 weeks in blood plasma, about 6 months in red blood cellsBuilds with daily use

  In the trial record, EPA in blood plasma plateaus after 4 to 8 weeks of daily fish oil, while EPA in the red blood cell membrane rises with a 28 day half-life and reaches a steady state at about 180 days.

  Katan et al., 1997 (J Lipid Res)PMID 9374124

  Promising
• EPAabout eight weeks of daily useBuilds with daily use

  In a randomised single-blind trial, 20 participants took either fish oil supplying 1,296 mg EPA and 864 mg DHA daily or flaxseed oil for eight weeks, with erythrocyte membrane and plasma samples drawn at weeks 0, 4, 8, 10, 12, 14, 16 and 24. On fish oil, erythrocyte membrane EPA rose 300 percent and DHA rose 42 percent by week eight. Levels held until about week 12 and then declined across the post-supplementation sampling, faster in plasma phospholipids than in erythrocyte membranes. Membrane fatty acid content was measured, not a symptom, and this is one trial of 20 people.

  Cao et al., 2006PMID 17053155

  Promising
• DHAabout five to seven days of daily useBuilds with daily use

  In a randomised double-blind crossover trial, healthy men and women aged 19 to 34 took capsules supplying about 4 g DHA per day, with plasma sampled at days 0, 1, 3, 7, 14 and 28. DHA concentrations tripled and so did DHA-derived oxylipins. Increases were detectable as early as day 1, and 11 of 12 individual DHA oxylipins plus total DHA oxylipins reached a plateau by days 5 to 7. The plateau came earlier and was reached by more oxylipins in females than in males. Plasma marker chemistry was measured, not a feeling.

  Gabbs et al., 2021PMID 33097936

  Promising

Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.

How each ingredient usually behaves over time.

Three ingredients, from each one's own page.

• Vitamin D3About six to twelve weeks

  25-hydroxyvitamin D climbs over roughly six to twelve weeks of daily dosing before it plateaus. It's a blood level you watch rather than a feeling.

  Its own page, the plain answer on timing ↗

• EPAThree months

  For the omega-3 index to settle at its new level. Triglyceride readings on a blood panel usually move sooner, inside four to eight weeks.

  Its own page, the plain answer on timing ↗

• DHA

  Membranes fill slowly. The omega 3 index moves over eight to twelve weeks, and the trials reporting cognitive or eye comfort changes run three to six months.

  Its own page, the plain answer on timing ↗

How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.

The same ingredient, carried differently.

What each form is, and where it fits in a formula. Measured findings carry the study that reported them.

• Cholecalciferol (vitamin D3)

  The animal-sourced form of vitamin D, made in skin under UVB light and produced commercially from lanolin. Fat-soluble, so it travels with dietary fat and is stored in body fat.

  Fits

  Raising and holding vitamin D status, and the form most supplement trials use.

  Trade-off

  Being fat-soluble it accumulates with sustained high dosing, so intakes are set against the tolerable upper level rather than topped up freely.

  In a 12-week double-blind randomised controlled trial in 108 young women in urban Bangalore, most of whom began vitamin D-deficient, daily vitamin D3 at 400, 600 or 800 IU in a fortified wafer raised serum 25-hydroxyvitamin D, parathyroid hormone fell over time, and effects on bone-turnover markers were modest and not dose specific. The 800 IU dose brought 65 percent of participants to sufficiency.

  Peris et al., 2026 (Nutrients)PMID 42124077

Descriptions of the form itself, read from the cited studies. Not a comparison between products and not a statement about any individual.

Softgel

It is a softgel, so the active is already dissolved in oil and the shell keeps it away from air and light.

Studied alongside this brand's other formulas

Where two of this brand's products carry actives the literature has read together, the pairing and its basis are below. The evidence word is the corpus row's own confidence, never a score.

Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.